Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vanguard Index FdsTotal Stock Market | 1,038,550 | 1,038,550 | 0 | $294.08M | $300.98M | 18.22% | +$6.91M |
| Brookfield CorporationCL A(BN) | 3,491,230 | 2,798,830 | -692,400 | $185.56M | $160.79M | 9.73% | -$24.77M |
| Tempus AI, Inc.CL A(TEM) | 4,074,419 | 4,074,419 | 0 | $230.61M | $137.55M | 8.33% | -$93.06M |
| Edgewise Therapeutics, Inc.(EWTX) | 5,549,900 | 5,000,000 | -549,900 | $148.13M | $133.50M | 8.08% | -$14.63M |
| Asml Holding N VN Y REGISTRY SHS N Y REGISTRY SHS | 133,336 | 165,836 | +32,500 | $111.10M | $114.94M | 6.96% | +$3.84M |
| Salesforce, Inc.(CRM) | 368,560 | 293,901 | -74,659 | $100.88M | $98.26M | 5.95% | -$2.62M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 0 | 10,114,633 | +10,114,633 | $0 | $68.37M | 4.14% | +$68.37M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,500,000 | 1,500,000 | 0 | $58.50M | $62.02M | 3.76% | +$3.52M |
| Vaxcyte, Inc.(PCVX) | 750,000 | 750,000 | 0 | $85.70M | $61.40M | 3.72% | -$24.31M |
| Insmed Incorporated(INSM) | 724,666 | 724,666 | 0 | $52.90M | $50.03M | 3.03% | -$2.87M |
| Crinetics Pharmaceuticals In | 1,000,000 | 960,215 | -39,785 | $51.10M | $49.10M | 2.97% | -$2.00M |
| Viridian Therapeutics, Inc.(VRDN) | 2,385,000 | 2,250,000 | -135,000 | $54.26M | $43.13M | 2.61% | -$11.13M |
| ArriVent BioPharma, Inc.(AVBP) | 1,505,315 | 1,520,627 | +15,312 | $35.37M | $40.51M | 2.45% | +$5.13M |
| Alibaba Group Holding LimitedADS(BABA) | 500,827 | 452,327 | -48,500 | $53.15M | $38.35M | 2.32% | -$14.79M |
| Pharvaris N V COM | 1,725,000 | 1,725,000 | 0 | $31.95M | $33.07M | 2.00% | +$1.12M |
| BioMarin Pharmaceutical Inc.(BMRN) | 490,000 | 490,000 | 0 | $34.44M | $32.21M | 1.95% | -$2.23M |
| Merus N V | 700,000 | 750,000 | +50,000 | $34.97M | $31.54M | 1.91% | -$3.43M |
| Celldex Therapeutics, Inc.(CLDX) | 963,663 | 1,000,000 | +36,337 | $32.75M | $25.27M | 1.53% | -$7.48M |
| Cargo Therapeutics Inc | 1,544,000 | 1,663,724 | +119,724 | $28.49M | $23.99M | 1.45% | -$4.50M |
| Amicus Therapeutics Inc COM | 2,500,000 | 2,500,000 | 0 | $26.70M | $23.55M | 1.43% | -$3.15M |
| LanzaTech Global, Inc.(LNZA) | 15,814,845 | 15,814,845 | 0 | $30.21M | $21.67M | 1.31% | -$8.54M |
| Blueprint Medicines Corp | 175,000 | 175,000 | 0 | $16.19M | $15.26M | 0.92% | -$924.0K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,100,000 | 1,100,000 | 0 | $20.32M | $13.83M | 0.84% | -$6.49M |
| Verve Therapeutics Inc | 2,400,000 | 2,400,000 | 0 | $11.62M | $13.54M | 0.82% | +$1.92M |
| Zenas BioPharma, Inc.(ZBIO) | 1,150,000 | 1,600,000 | +450,000 | $19.46M | $13.10M | 0.79% | -$6.35M |
| CeriBell, Inc.(CBLL) | 0 | 328,809 | +328,809 | $0 | $8.51M | 0.52% | +$8.51M |
| 4d Molecular Therapeutics In | 1,500,000 | 1,500,000 | 0 | $16.21M | $8.36M | 0.51% | -$7.86M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,122,581 | 1,122,581 | 0 | $10.15M | $7.39M | 0.45% | -$2.76M |
| Kyverna Therapeutics, Inc.(KYTX) | 1,850,000 | 1,850,000 | 0 | $9.05M | $6.92M | 0.42% | -$2.13M |
| Mersana Therapeutics Inc. | 0 | 4,250,000 | +4,250,000 | $0 | $6.08M | 0.37% | +$6.08M |
| AbCellera Biologics Inc.(ABCL) | 1,126,915 | 1,126,915 | 0 | $2.93M | $3.30M | 0.20% | +$371.9K |
| Io Biotech Inc | 3,354,449 | 3,354,449 | 0 | $3.52M | $3.09M | 0.19% | -$436.1K |
| Marqeta, Inc.CL A(MQ) | 441,558 | 441,558 | 0 | $2.17M | $1.67M | 0.10% | -$499.0K |
| Damora Therapeutics, Inc.(DMRA) | 99,913 | 99,913 | 0 | $1.21M | $464.6K | 0.03% | -$749.3K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 118,383 | 0 | -118,383 | $32.56M | $0 | — | -$32.56M |
| Brookfield Asset Management Ltd.CL A(BAM) | 627,207 | 0 | -627,207 | $29.66M | $0 | — | -$29.66M |
| Cable One, Inc.(CABO) | 118,403 | 0 | -118,403 | $41.42M | $0 | — | -$41.42M |
| Corcept Therapeutics Incorporated(CORT) | 2,411,362 | 0 | -2,411,362 | $111.60M | $0 | — | -$111.60M |
| Metagenomi Therapeutics, Inc.(MGX) | 1,800,000 | 0 | -1,800,000 | $3.91M | $0 | — | -$3.91M |
| Spero Therapeutics, Inc.(SPRO) | 468,902 | 0 | -468,902 | $628.3K | $0 | — | -$628.3K |